Analysts expect Halyard Health, Inc. (NYSE:HYH) to post $0.50 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Halyard Health’s earnings, with the lowest EPS estimate coming in at $0.49 and the highest estimate coming in at $0.51. Halyard Health also reported earnings of $0.50 per share during the same quarter last year. The company is expected to issue its next earnings results on Monday, February 26th.

According to Zacks, analysts expect that Halyard Health will report full-year earnings of $2.02 per share for the current fiscal year, with EPS estimates ranging from $1.91 to $2.09. For the next financial year, analysts expect that the business will post earnings of $2.14 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover Halyard Health.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.13. The firm had revenue of $401.40 million for the quarter, compared to analyst estimates of $394.54 million. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. Halyard Health’s revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.48 earnings per share.

A number of equities research analysts have commented on the company. Zacks Investment Research lowered Halyard Health from a “buy” rating to a “sell” rating in a research report on Wednesday, October 4th. BidaskClub upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. KeyCorp restated a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Finally, TheStreet lowered Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $46.25.

Hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC bought a new position in shares of Halyard Health in the 1st quarter valued at approximately $727,000. Koch Industries Inc. bought a new position in shares of Halyard Health in the 2nd quarter valued at approximately $297,000. TIAA CREF Investment Management LLC raised its stake in shares of Halyard Health by 35.2% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 202,901 shares of the medical instruments supplier’s stock valued at $7,970,000 after acquiring an additional 52,881 shares in the last quarter. Prudential Financial Inc. raised its stake in shares of Halyard Health by 3.9% in the 3rd quarter. Prudential Financial Inc. now owns 686,309 shares of the medical instruments supplier’s stock valued at $30,904,000 after acquiring an additional 25,680 shares in the last quarter. Finally, Sterling Capital Management LLC bought a new position in shares of Halyard Health in the 2nd quarter valued at approximately $631,000. 90.31% of the stock is currently owned by institutional investors and hedge funds.

Halyard Health (NYSE HYH) traded down $0.56 during trading hours on Tuesday, hitting $46.89. The company had a trading volume of 260,700 shares, compared to its average volume of 345,800. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19. Halyard Health has a fifty-two week low of $35.24 and a fifty-two week high of $50.99. The firm has a market cap of $2,222.39, a price-to-earnings ratio of 22.70, a price-to-earnings-growth ratio of 2.56 and a beta of 1.77.

COPYRIGHT VIOLATION NOTICE: “Halyard Health, Inc. (HYH) Expected to Announce Earnings of $0.50 Per Share” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/12/halyard-health-inc-hyh-expected-to-announce-earnings-of-0-50-per-share-3.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Get a free copy of the Zacks research report on Halyard Health (HYH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.